Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zwierzina

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2008
Biomarkers in drug developmentH Zwierzina
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Meeting Report: First Meeting of the "Task Force Cytokines" of the EORTC Research BranchH Zwierzina
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
Combining immunotherapy with classical anticancer therapyH Zwierzina
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Biological response modifiersH Zwierzina
Stem Cells (Dayton, Ohio)|May 1, 1993
Practical aspects of cytokine therapyH Zwierzina
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Immune monitoring of cancer vaccines. Report on a workshop held at the 9th NCI-EORTC Symposium on New Drugs in Cancer TherapyM Sznol, H Zwierzina
Leukemia Research|June 1, 1992
Increased serum interleukin 6 levels in patients with myelodysplastic syndromesM Herold, F Schmalzl, H Zwierzina
Acta Medica Austriaca|January 1, 1991
[In vitro effects and possible clinical relevance of interleukin 3]H Zwierzina, F Schmalzl, H Braunsteiner
Cancer Treatment Reviews|January 22, 2019
Innovation in oncology clinical trial designJ Verweij, H R Hendriks, H Zwierzina, et al.
Leukemia|February 1, 1991
Therapy of myelodysplastic syndromes: advances and perspectives. Innsbruck, Austria, October 7-10, 1990H Zwierzina, G J Mufti, F Schmalzl
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2008
Biomarkers in drug developmentH Zwierzina
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Meeting Report: First Meeting of the "Task Force Cytokines" of the EORTC Research BranchH Zwierzina
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
Combining immunotherapy with classical anticancer therapyH Zwierzina
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Biological response modifiersH Zwierzina
Stem Cells (Dayton, Ohio)|May 1, 1993
Practical aspects of cytokine therapyH Zwierzina
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Immune monitoring of cancer vaccines. Report on a workshop held at the 9th NCI-EORTC Symposium on New Drugs in Cancer TherapyM Sznol, H Zwierzina
Leukemia Research|June 1, 1992
Increased serum interleukin 6 levels in patients with myelodysplastic syndromesM Herold, F Schmalzl, H Zwierzina
Acta Medica Austriaca|January 1, 1991
[In vitro effects and possible clinical relevance of interleukin 3]H Zwierzina, F Schmalzl, H Braunsteiner
Cancer Treatment Reviews|January 22, 2019
Innovation in oncology clinical trial designJ Verweij, H R Hendriks, H Zwierzina, et al.
Leukemia|February 1, 1991
Therapy of myelodysplastic syndromes: advances and perspectives. Innsbruck, Austria, October 7-10, 1990H Zwierzina, G J Mufti, F Schmalzl
Pageof 7